000150515512/312026Q1falseP7Y15,2500.00111158xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesupld:customerxbrli:pureupld:directorupld:voteupld:segment00015051552026-01-012026-03-310001505155us-gaap:CommonStockMember2026-01-012026-03-310001505155upld:PreferredStockPurchaseRightsMember2026-01-012026-03-3100015051552026-04-2900015051552026-03-3100015051552025-12-310001505155upld:SubscriptionAndSupportMember2026-01-012026-03-310001505155upld:SubscriptionAndSupportMember2025-01-012025-03-310001505155upld:PerpetualLicenseMember2026-01-012026-03-310001505155upld:PerpetualLicenseMember2025-01-012025-03-310001505155us-gaap:ProductMember2026-01-012026-03-310001505155us-gaap:ProductMember2025-01-012025-03-310001505155upld:ProfessionalServicesMember2026-01-012026-03-310001505155upld:ProfessionalServicesMember2025-01-012025-03-3100015051552025-01-012025-03-310001505155us-gaap:CommonStockMember2025-12-310001505155us-gaap:AdditionalPaidInCapitalMember2025-12-310001505155us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001505155us-gaap:RetainedEarningsMember2025-12-310001505155us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001505155us-gaap:CommonStockMember2026-01-012026-03-310001505155us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001505155us-gaap:RetainedEarningsMember2026-01-012026-03-310001505155us-gaap:CommonStockMember2026-03-310001505155us-gaap:AdditionalPaidInCapitalMember2026-03-310001505155us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001505155us-gaap:RetainedEarningsMember2026-03-3100015051552024-12-310001505155us-gaap:CommonStockMember2024-12-310001505155us-gaap:AdditionalPaidInCapitalMember2024-12-310001505155us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001505155us-gaap:RetainedEarningsMember2024-12-310001505155us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001505155us-gaap:CommonStockMember2025-01-012025-03-310001505155us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001505155us-gaap:RetainedEarningsMember2025-01-012025-03-3100015051552025-03-310001505155us-gaap:CommonStockMember2025-03-310001505155us-gaap:AdditionalPaidInCapitalMember2025-03-310001505155us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001505155us-gaap:RetainedEarningsMember2025-03-310001505155us-gaap:FairValueInputsLevel1Member2026-03-310001505155us-gaap:FairValueInputsLevel2Member2026-03-310001505155us-gaap:FairValueInputsLevel3Member2026-03-310001505155us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2026-03-310001505155us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2026-03-310001505155us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2026-03-310001505155us-gaap:InterestRateSwapMember2026-03-310001505155us-gaap:FairValueInputsLevel1Member2025-12-310001505155us-gaap:FairValueInputsLevel2Member2025-12-310001505155us-gaap:FairValueInputsLevel3Member2025-12-310001505155us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2025-12-310001505155us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2025-12-310001505155us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2025-12-310001505155us-gaap:InterestRateSwapMember2025-12-310001505155srt:MinimumMemberus-gaap:CustomerRelationshipsMember2026-03-310001505155srt:MaximumMemberus-gaap:CustomerRelationshipsMember2026-03-310001505155us-gaap:CustomerRelationshipsMember2026-03-310001505155srt:MinimumMemberus-gaap:TradeNamesMember2026-03-310001505155srt:MaximumMemberus-gaap:TradeNamesMember2026-03-310001505155us-gaap:TradeNamesMember2026-03-310001505155srt:MinimumMemberus-gaap:DevelopedTechnologyRightsMember2026-03-310001505155srt:MaximumMemberus-gaap:DevelopedTechnologyRightsMember2026-03-310001505155us-gaap:DevelopedTechnologyRightsMember2026-03-310001505155us-gaap:OffMarketFavorableLeaseMember2026-03-310001505155srt:MinimumMemberus-gaap:CustomerRelationshipsMember2025-12-310001505155srt:MaximumMemberus-gaap:CustomerRelationshipsMember2025-12-310001505155us-gaap:CustomerRelationshipsMember2025-12-310001505155srt:MinimumMemberus-gaap:TradeNamesMember2025-12-310001505155srt:MaximumMemberus-gaap:TradeNamesMember2025-12-310001505155us-gaap:TradeNamesMember2025-12-310001505155srt:MinimumMemberus-gaap:DevelopedTechnologyRightsMember2025-12-310001505155srt:MaximumMemberus-gaap:DevelopedTechnologyRightsMember2025-12-310001505155us-gaap:DevelopedTechnologyRightsMember2025-12-310001505155us-gaap:OffMarketFavorableLeaseMember2025-12-310001505155upld:SeniorSecuredNotesMember2026-03-310001505155upld:SeniorSecuredNotesMember2025-12-310001505155upld:TermLoanMemberus-gaap:SecuredDebtMember2025-07-250001505155us-gaap:RevolvingCreditFacilityMemberupld:SeniorSecuredRevolvingCreditFacilityMember2025-07-250001505155upld:CreditFacilityMembersrt:MinimumMemberus-gaap:SecuredDebtMember2025-07-252025-07-250001505155upld:CreditFacilityMembersrt:MaximumMemberus-gaap:SecuredDebtMember2025-07-252025-07-250001505155upld:TermLoanMemberus-gaap:SecuredDebtMember2026-03-310001505155upld:CreditFacilityMemberus-gaap:DebtInstrumentRedemptionPeriodOneMemberus-gaap:SecuredDebtMember2025-07-252025-07-250001505155upld:CreditFacilityMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberus-gaap:SecuredDebtMember2025-07-252025-07-250001505155upld:CreditFacilityMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMemberus-gaap:SecuredDebtMember2025-07-252025-07-250001505155upld:CreditFacilityMemberus-gaap:SecuredDebtMember2026-03-310001505155upld:CreditFacilityMemberus-gaap:SecuredDebtMember2025-12-310001505155upld:CreditFacilityMemberus-gaap:SecuredDebtMember2025-07-250001505155upld:TermLoanMemberus-gaap:SecuredDebtMember2025-07-252025-07-250001505155us-gaap:InterestRateCapMember2025-09-300001505155us-gaap:InterestRateSwapMember2026-01-012026-03-310001505155us-gaap:InterestRateSwapMember2025-01-012025-03-310001505155upld:InterestRateDerivativesMember2026-01-012026-03-310001505155upld:InterestRateDerivativesMember2025-01-012025-03-310001505155us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001505155us-gaap:EmployeeStockOptionMember2025-01-012025-03-310001505155us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310001505155us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310001505155us-gaap:PerformanceSharesMember2026-01-012026-03-310001505155us-gaap:PerformanceSharesMember2025-01-012025-03-310001505155us-gaap:SeriesAPreferredStockMember2026-01-012026-03-310001505155us-gaap:SeriesAPreferredStockMember2025-01-012025-03-310001505155us-gaap:SeriesAPreferredStockMember2026-03-3100015051552022-08-232022-08-2300015051552022-08-230001505155upld:BeforeSevenYearAnniversaryMember2022-08-232022-08-230001505155upld:AfterSevenYearAnniversaryMember2022-08-232022-08-230001505155upld:A2025ShareRepurchasePlanMember2025-08-1500015051552025-08-150001505155upld:A2025ShareRepurchasePlanMember2026-03-310001505155upld:PreferredStockPurchaseRightsMember2024-06-052024-06-050001505155upld:PreferredStockPurchaseRightsMember2024-06-0500015051552024-06-050001505155us-gaap:AccumulatedTranslationAdjustmentMember2026-03-310001505155us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310001505155upld:AccumulatedForeignCurrencyAdjustmentAttributableToParentForeignCurrencyDenominatedIntercompanyLoansMember2026-03-310001505155upld:AccumulatedForeignCurrencyAdjustmentAttributableToParentForeignCurrencyDenominatedIntercompanyLoansMember2025-12-310001505155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-03-310001505155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-12-310001505155upld:AccumulatedForeignCurrencyAdjustmentAttributableToParentForeignCurrencyDenominatedIntercompanyLoansWithForeignSubsidiariesTaxMember2026-01-012026-03-310001505155upld:AccumulatedForeignCurrencyAdjustmentAttributableToParentForeignCurrencyDenominatedIntercompanyLoansWithForeignSubsidiariesTaxMember2025-01-012025-12-310001505155upld:PerformanceRestrictedStockUnitsAndRestrictedStockUnitsMember2025-12-310001505155upld:PerformanceRestrictedStockUnitsAndRestrictedStockUnitsMember2026-01-012026-03-310001505155upld:PerformanceRestrictedStockUnitsAndRestrictedStockUnitsMember2026-03-310001505155us-gaap:PerformanceSharesMember2026-01-012026-03-310001505155us-gaap:PerformanceSharesMember2026-03-310001505155srt:MaximumMemberus-gaap:PerformanceSharesMember2026-01-012026-03-310001505155upld:CostOfRevenueMember2026-01-012026-03-310001505155upld:CostOfRevenueMember2025-01-012025-03-310001505155us-gaap:ResearchAndDevelopmentExpenseMember2026-01-012026-03-310001505155us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001505155us-gaap:SellingAndMarketingExpenseMember2026-01-012026-03-310001505155us-gaap:SellingAndMarketingExpenseMember2025-01-012025-03-310001505155us-gaap:GeneralAndAdministrativeExpenseMember2026-01-012026-03-310001505155us-gaap:GeneralAndAdministrativeExpenseMember2025-01-012025-03-3100015051552026-04-012026-03-310001505155us-gaap:DisposalGroupNotDiscontinuedOperationsMemberupld:CertainProductLinesMember2026-01-012026-03-310001505155us-gaap:DisposalGroupNotDiscontinuedOperationsMemberupld:CertainProductLinesMember2026-03-310001505155us-gaap:DisposalGroupNotDiscontinuedOperationsMemberupld:CertainProductLinesMembersrt:MinimumMember2026-01-012026-03-310001505155us-gaap:DisposalGroupNotDiscontinuedOperationsMemberupld:CertainProductLinesMembersrt:MaximumMember2026-01-012026-03-310001505155us-gaap:DisposalGroupNotDiscontinuedOperationsMemberupld:CertainProductLinesMember2025-03-310001505155us-gaap:DisposalGroupNotDiscontinuedOperationsMemberupld:CertainProductLinesMember2025-01-012025-03-310001505155upld:TimothyMattoxMember2026-01-012026-03-310001505155upld:TimothyMattoxMember2026-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2026
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-36720
UPLAND SOFTWARE, INC.
(Exact name of registrant as specified in its charter)
| | | | | |
| Delaware | 27-2992077 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
900 S. Capital of Texas Highway, Las Cimas IV Suite 300
Austin, Texas 78746
(Address, including zip code, of registrant’s principal executive offices)
(512) 960-1010
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol | | Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share | | UPLD | | The Nasdaq Global Market |
| Preferred Stock Purchase Rights | | - | | The Nasdaq Global Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act. | | | | | | | | | | | | | | |
| Large accelerated filer | ☐ | | Accelerated filer | ☐ |
| | | | |
| Non-accelerated filer | x | | Smaller reporting company | x |
| | | | |
| | | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
As of April 29, 2026, 29,363,201 shares of the registrant’s Common Stock were outstanding.
Upland Software, Inc.
Table of Contents | | | | | | | | |
| | Page |
Part I. | FINANCIAL INFORMATION | |
Item 1. | Financial Statements | |
| Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 | 1 |
| Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and March 31, 2025 | 2 |
| Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended March 31, 2026 and March 31, 2025 | 3 |
| Condensed Consolidated Statements of Stockholders' Deficit for the Three Months Ended March 31, 2026 and March 31, 2025 | 4 |
| Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and March 31, 2025 | 5 |
| Notes to Unaudited Condensed Consolidated Financial Statements | 6 |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 18 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 27 |
Item 4. | Controls and Procedures | 27 |
Part II. | OTHER INFORMATION | 28 |
Item 1. | Legal Proceedings | 28 |
Item 1A. | Risk Factors | 28 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 28 |
Item 5. | Other Information | 28 |
Item 6. | Exhibits | 29 |
Exhibit Index | 30 |
Signature | 31 |
| | |
Upland Software, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except for share and per share amounts)
Item 1. Financial Statements
| | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | March 31, 2026 | | December 31, 2025 | | | | |
| | | (unaudited) | | | | | | |
| ASSETS | | | | | | | | |
| Current assets: | | | | | | | | |
| Cash and cash equivalents | | $ | 29,781 | | | $ | 29,398 | | | | | |
| Restricted cash | | 626 | | | 626 | | | | | |
Accounts receivable (net of allowance of $64 and $140 at March 31, 2026, and December 31, 2025, respectively) | | 23,622 | | | 25,603 | | | | | |
| Deferred commissions, current | | 5,448 | | | 5,660 | | | | | |
| Unbilled receivables | | 4,125 | | | 3,981 | | | | | |
| Income tax receivable, current | | 2,789 | | | 1,832 | | | | | |
| Prepaid expenses and other current assets | | 7,123 | | | 8,154 | | | | | |
| Total current assets | | 73,514 | | | 75,254 | | | | | |
| Tax credits receivable | | 841 | | | 863 | | | | | |
| Property and equipment, net | | 1,672 | | | 1,815 | | | | | |
| Operating lease right-of-use asset | | 1,552 | | | 1,713 | | | | | |
| Intangible assets, net | | 55,358 | | | 62,317 | | | | | |
| Goodwill | | 258,276 | | | 259,631 | | | | | |
| Deferred commissions, noncurrent | | 7,866 | | | 7,865 | | | | | |
| Interest rate derivatives | | 105 | | | 15 | | | | | |
| Other assets | | 3,476 | | | 3,704 | | | | | |
| Total assets | | $ | 402,660 | | | $ | 413,177 | | | | | |
| LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT | | | | |
| Current liabilities: | | | | | | | | |
| Accounts payable | | $ | 2,291 | | | $ | 2,140 | | | | | |
| Accrued compensation | | 3,984 | | | 4,358 | | | | | |
| Accrued expenses and other current liabilities | | 2,324 | | | 3,938 | | | | | |
| Deferred revenue | | 73,746 | | | 74,768 | | | | | |
| | | | | | | | |
| Operating lease liabilities, current | | 759 | | | 817 | | | | | |
Current maturities of notes payable (includes unamortized discount of $1,164 and $1,133 at March 31, 2026, and December 31, 2025, respectively) | | 4,127 | | | 7,739 | | | | | |
| Total current liabilities | | 87,231 | | | 93,760 | | | | | |
| | | | | | | | |
Notes payable, less current maturities (includes unamortized discount of $4,842 and $4,961 at March 31, 2026, and December 31, 2025, respectively) | | 223,545 | | | 224,667 | | | | | |
| Deferred revenue, noncurrent | | 4,692 | | | 4,841 | | | | | |
| Operating lease liabilities, noncurrent | | 1,849 | | | 1,971 | | | | | |
| Noncurrent deferred tax liability, net | | 6,631 | | | 6,723 | | | | | |
| | | | | | | | |
| Other long-term liabilities | | 519 | | | 505 | | | | | |
| Total liabilities | | 324,467 | | | 332,467 | | | | | |
| Mezzanine equity: | | | | | | | | |
Series A Convertible Preferred stock, $0.0001 par value; 5,000,000 shares authorized; 115,000 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively | | 130,581 | | | 129,078 | | | | | |
| Stockholders’ deficit: | | | | | | | | |
Common stock, $0.0001 par value; 75,000,000 shares authorized; 29,363,201 and 29,118,178 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively | | 3 | | | 3 | | | | | |
| Additional paid-in capital | | 606,659 | | | 607,275 | | | | | |
| Accumulated other comprehensive loss | | (17,312) | | | (15,138) | | | | | |
| Accumulated deficit | | (641,738) | | | (640,508) | | | | | |
| Total stockholders’ deficit | | (52,388) | | | (48,368) | | | | | |
| Total liabilities, convertible preferred stock and stockholders’ deficit | | $ | 402,660 | | | $ | 413,177 | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Upland Software, Inc.
Condensed Consolidated Statements of Operations
(unaudited)
(in thousands, except for share and per share amounts)
| | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| | | Three Months Ended March 31, | | |
| | | 2026 | | 2025 | | | | |
| Revenue: | | | | | | | | |
| Subscription and support | | $ | 46,091 | | | $ | 60,182 | | | | | |
| Perpetual license | | 1,295 | | | 1,608 | | | | | |
| Total product revenue | | 47,386 | | | 61,790 | | | | | |
| Professional services | | 1,304 | | | 1,865 | | | | | |
| Total revenue | | 48,690 | | | 63,655 | | | | | |
| Cost of revenue: | | | | | | | | |
| Subscription and support | | 11,112 | | | 16,950 | | | | | |
| Professional services and other | | 822 | | | 1,098 | | | | | |
| Total cost of revenue | | 11,934 | | | 18,048 | | | | | |
| Gross profit | | 36,756 | | | 45,607 | | | | | |
| Operating expenses: | | | | | | | | |
| Sales and marketing | | 9,472 | | | 13,756 | | | | | |
| Research and development | | 8,044 | | | 11,542 | | | | | |
| | | | | | | | |
| General and administrative | | 8,538 | | | 11,621 | | | | | |
| Depreciation and amortization | | 5,631 | | | 7,995 | | | | | |
| Divestiture-related expenses | | 22 | | | 1,745 | | | | | |
| | | | | | | | |
| Total operating expenses | | 31,707 | | | 46,659 | | | | | |
| Income (loss) from operations | | 5,049 | | | (1,052) | | | | | |
| Other income (expense): | | | | | | | | |
| Interest expense, net | | (4,459) | | | (2,443) | | | | | |
| Loss on divestitures of businesses | | — | | | (23,457) | | | | | |
| | | | | | | | |
| Other expense, net | | (834) | | | (241) | | | | | |
| Total other expense, net | | (5,293) | | | (26,141) | | | | | |
| Loss before benefit from (provision for) income taxes | | (244) | | | (27,193) | | | | | |
| Benefit from (provision for) income taxes | | (986) | | | 1,345 | | | | | |
| | | | | | | | |
| | | | | | | | |
| Net loss | | $ | (1,230) | | | $ | (25,848) | | | | | |
| Preferred stock dividends | | (1,503) | | | (1,438) | | | | | |
| Net loss attributable to common stockholders | | $ | (2,733) | | | $ | (27,286) | | | | | |
| Net loss per common share: | | | | | | | | |
| Net loss per common share, basic and diluted | | $ | (0.09) | | | $ | (0.97) | | | | | |
| | | | | | | | |
| | | | | | | | |
| Weighted-average common shares outstanding, basic and diluted | | 29,159,015 | | | 28,220,936 | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Upland Software, Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(unaudited)
(in thousands)
| | | | | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, | | |
| | | 2026 | | 2025 | | | | |
| Net loss | | $ | (1,230) | | | $ | (25,848) | | | | | |
| Other comprehensive income (loss): | | | | | | | | |
| Unrealized foreign currency translation adjustment | | (1,108) | | | 2,264 | | | | | |
| Realized foreign currency gain | | — | | | 5,715 | | | | | |
| Unrealized translation gain on foreign currency denominated intercompany loans, net of taxes | | 71 | | | 1,498 | | | | | |
| Interest rate swaps, net of reclassifications into earnings | | (1,137) | | | (3,890) | | | | | |
Other comprehensive income (loss): | | $ | (2,174) | | | $ | 5,587 | | | | | |
| Comprehensive loss | | $ | (3,404) | | | $ | (20,261) | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Upland Software, Inc.
Condensed Consolidated Statements of Stockholders’ Deficit
(unaudited)
(in thousands, except share amounts)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2026 |
| Preferred Stock | | Common Stock | | Additional Paid-In Capital | | Accumulated Other Comprehensive Income (Loss) | | Accumulated Deficit | | Total Stockholders’ Equity (Deficit) |
| | Shares | | Amount | | Shares | | Amount | |
| Balance at December 31, 2025 | 115,000 | | | $ | 129,078 | | | 29,118,178 | | | $ | 3 | | | $ | 607,275 | | | $ | (15,138) | | | $ | (640,508) | | | $ | (48,368) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Dividends accrued - Convertible Preferred Stock | — | | | 1,503 | | | — | | | — | | | (1,503) | | | — | | | — | | | (1,503) | |
| Issuance of stock under Company plans, net of shares withheld for tax | — | | | — | | | 245,023 | | | — | | | (74) | | | — | | | — | | | (74) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Stock-based compensation | — | | | — | | | — | | | — | | | 961 | | | — | | | — | | | 961 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Unrealized foreign currency translation adjustment | — | | | — | | | — | | | — | | | — | | | (1,108) | | | — | | | (1,108) | |
| | | | | | | | | | | | | | | |
Unrealized translation gain on intercompany loans with foreign subsidiaries | — | | | — | | | — | | | — | | | — | | | 71 | | | — | | | 71 | |
| Interest rate swaps | — | | | — | | | — | | | — | | | — | | | (1,137) | | | — | | | (1,137) | |
| Net loss | | | | | — | | | — | | | — | | | — | | | (1,230) | | | (1,230) | |
| Balance at March 31, 2026 | 115,000 | | | $ | 130,581 | | | 29,363,201 | | | $ | 3 | | | $ | 606,659 | | | $ | (17,312) | | | $ | (641,738) | | | $ | (52,388) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2025 |
| Preferred Stock | | Common Stock | | Additional Paid-In Capital | | Accumulated Other Comprehensive Income (Loss) | | Accumulated Deficit | | Total Stockholders’ Equity (Deficit) |
| Shares | | Amount | | Shares | | Amount | |
| Balance at December 31, 2024 | 115,000 | | | $ | 123,230 | | | 28,168,267 | | | $ | 3 | | | $ | 605,286 | | | $ | (21,990) | | | $ | (601,604) | | | $ | (18,305) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Dividends accrued - Convertible Preferred Stock | — | | | 1,438 | | | — | | | — | | | (1,438) | | | — | | | — | | | (1,438) | |
| Issuance of stock under Company plans, net of shares withheld for tax | — | | | — | | | 316,012 | | | — | | | (494) | | | — | | | — | | | (494) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Stock-based compensation | — | | | — | | | — | | | — | | | 2,675 | | | — | | | — | | | 2,675 | |
Realized translation gain on divestitures of businesses | — | | | — | | | — | | | — | | | — | | | 5,715 | | | — | | | 5,715 | |
| Foreign currency translation adjustment | — | | | — | | | — | | | — | | | — | | | 2,264 | | | — | | | 2,264 | |
Unrealized translation gain on intercompany loans with foreign subsidiaries | — | | | — | | | — | | | — | | | — | | | 1,498 | | | — | | | 1,498 | |
| Interest rate swaps | — | | | — | | | — | | | — | | | — | | | (3,890) | | | — | | | (3,890) | |
| Net loss | — | | | — | | | — | | | — | | | — | | | — | | | (25,848) | | | (25,848) | |
| Balance at March 31, 2025 | 115,000 | | | $ | 124,668 | | | 28,484,279 | | | $ | 3 | | | $ | 606,029 | | | $ | (16,403) | | | $ | (627,452) | | | $ | (37,823) | |
| | | | | | | | | | | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| | | | | | | | | | | | | | |
| Upland Software, Inc. |
| Condensed Consolidated Statements of Cash Flows |
| (unaudited) |
| (in thousands) |
|
| | | Three Months Ended March 31, |
| | 2026 | | 2025 |
| Operating activities | | | | |
| Net loss | | $ | (1,230) | | | $ | (25,848) | |
| Adjustments to reconcile net loss to net cash provided by operating activities: | | | | |
| Depreciation and amortization | | 6,624 | | | 9,661 | |
| | | | |
| Deferred income taxes | | 4 | | | (3,078) | |
| Amortization of deferred costs | | 1,687 | | | 2,735 | |
Foreign currency re-measurement loss | | 882 | | | 460 | |
| Non-cash interest, net and other income, net | | (899) | | | (1,186) | |
| Non-cash stock-based compensation expense | | 961 | | | 2,675 | |
| | | | |
| | | | |
| | | | |
| Non-cash loss on divestitures of businesses | | — | | | 23,457 | |
| Non-cash loss on retirement of fixed assets | | 2 | | | 2 | |
| | | | |
| Changes in operating assets and liabilities: | | | | |
| Accounts receivable | | 1,865 | | | 7,971 | |
| Prepaid expenses and other current assets | | (145) | | | (2,519) | |
| Other assets | | (1,529) | | | (1,967) | |
| Accounts payable | | 164 | | | (7,198) | |
| Accrued expenses and other liabilities | | (1,905) | | | 2,494 | |
| Deferred revenue | | (878) | | | 646 | |
| Net cash provided by operating activities | | 5,603 | | | 8,305 | |
| Investing activities | | | | |
| Purchase of property and equipment | | (81) | | | (424) | |
| | | | |
| Collections on note receivable | | 177 | | | — | |
Proceeds from the divestitures of businesses, net of cash transferred | | — | | | 4,213 | |
| | | | |
| Net cash provided by investing activities | | 96 | | | 3,789 | |
| Financing activities | | | | |
| | | | |
| | | | |
| Payments on notes payable | | (4,822) | | | (34,226) | |
| Payments of debt issuance costs | | (213) | | | (3) | |
| | | | |
| | | | |
| | | | |
| | | | |
| Taxes paid related to net share settlement of equity awards | | (74) | | | (494) | |
| | | | |
| | | | |
| | | | |
| Net cash used in financing activities | | (5,109) | | | (34,723) | |
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | | (207) | | | (92) | |
| Change in cash, cash equivalents and restricted cash | | 383 | | | (22,721) | |
| Cash, cash equivalents and restricted cash, beginning of period | | 30,024 | | | 57,052 | |
| Cash, cash equivalents and restricted cash, end of period | | $ | 30,407 | | | $ | 34,331 | |
| Supplemental disclosures of cash flow information: | | | | |
| Cash paid for interest, net of interest rate derivatives | | $ | 5,814 | | | $ | 4,162 | |
| Cash paid for taxes, net of refunds | | $ | 2,869 | | | $ | 1,976 | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Upland Software, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
(unaudited)
1. Organization and Nature of Operations
Upland Software, Inc., together with its wholly owned subsidiaries (“Upland,” “we,” “us,” “our,” or the “Company”), a Delaware corporation headquartered in Austin, Texas, is a leader in AI-powered knowledge and content management software. Our solutions help enterprises unlock critical knowledge, automate content workflows, and drive measurable ROI—enhancing customer and employee experiences while supporting regulatory compliance. More than 1,100 enterprise customers rely on Upland to solve complex challenges and provide a trusted path for AI adoption. The Company's customers operate in a wide variety of industries, including financial services, consulting services, technology, manufacturing, media, telecommunications, government, insurance, non-profit, healthcare, life sciences, retail, and hospitality.
2. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
These condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The condensed consolidated financial statements include the accounts of Upland Software, Inc. and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. No material changes have been made to the Company’s significant accounting policies disclosed in Note 2, Basis of Presentation and Summary of Significant Accounting Policies, in the Company’s Annual Report.
The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. In the opinion of management of the Company, the unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements, in all material respects, and include all adjustments of a normal recurring nature necessary for a fair presentation. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any other period.
The financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s 2025 Annual Report on Form 10-K.
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses. Significant items subject to such estimates include those related to revenue recognition, deferred commissions, allowance for credit losses, stock-based compensation, impairment of goodwill, intangibles and long-lived assets, the useful lives of intangible assets and property and equipment, the fair value of the Company’s interest rate derivatives and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ from those estimates.
Upland is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of May 1, 2026, the date of issuance of this Quarterly Report on Form 10-Q. These estimates may change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.
Restricted Cash
The Company is required to maintain a letter of credit as collateral during the term of an operating lease for office space. As of March 31, 2026 and December 31, 2025, we had $0.6 million of restricted cash deposited in a restricted account as collateral for the letter of credit. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statements of cash flows (in thousands):
| | | | | | | | | | | | | | | | | |
| | | | | |
| | 3/31/2026 | | 12/31/2025 | |
| Cash and cash equivalents | | $ | 29,781 | | | $ | 29,398 | | |
| Restricted cash | | 626 | | | 626 | | |
| Total cash, cash equivalents and restricted cash | | $ | 30,407 | | | $ | 30,024 | | |
Concentrations of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, accounts receivable, and other assets. The Company’s cash and cash equivalents are placed with high quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in these accounts, and the Company does not believe it is exposed to any significant credit risk related to cash and cash equivalents. The Company provides credit, in the normal course of business, to a number of its customers and generally does not require collateral. To manage accounts receivable credit risk, the Company performs periodic credit evaluations of its customers and maintains current expected credit losses which considers such factors as historical loss information, geographic location of customers, current market conditions, and reasonable and supportable forecasts.
No individual customer represented more than 10% of total revenues for the three months ended March 31, 2026 or March 31, 2025 and no individual customer represented more than 10% of accounts receivable as of March 31, 2026 or December 31, 2025.
Recent Accounting Pronouncements
Recently issued accounting pronouncements - Adopted
In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05 Measurement of Credit Losses for Accounts Receivable and Contract Assets related to credit losses for accounts receivable and contract assets. ASU 2025-05 provides a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current accounts receivable and current contract assets. This ASU is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years, with early adoption permitted. Entities that elect the practical expedient and, if applicable, make the accounting policy election are required to apply the amendments prospectively. The Company adopted the standard on January 1, 2026, on a prospective basis and elected to apply the practical expedient to its estimate of expected credit losses for current accounts receivable and current contract assets. The adoption did not have a material impact on the Company’s consolidated financial statements.
In November 2024, the FASB issued ASU 2024-04, Debt-Debt with Conversions and Other Options. ASU 2024-04 is intended to clarify requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. This ASU is effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company adopted this guidance effective January 1, 2026. The adoption did not have a material impact on the Company’s consolidated financial statements.
Recently issued accounting pronouncements - Not Adopted
In September 2025, the FASB issued accounting standards update (“ASU”) 2025-07 Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract. ASU 2025-07 expands the scope exception for certain contracts not traded on an exchange to include contracts for which settlement is based on operations or activities specific to one of the parties to the contract. This improvement is expected to result in more contracts and embedded features being excluded from the scope of Topic 815. This ASU is effective for annual periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on its consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06 Intangibles—Goodwill and Other—Internal-Use Software Targeted Improvements to the Accounting for Internal-Use Software related to accounting for internal-use software costs. ASU 2025-06 improves the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. This ASU is effective for annual periods beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on its consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures. ASU 2024-03 (as clarified by ASU 2025-01) is intended to improve disclosures about a public business entity’s expense and provide more detailed information to investors about the types of expenses in commonly presented expense captions. This ASU is effective for public companies with annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on its consolidated financial statements.
3. Fair Value Measurements
The Company recognizes financial instruments in accordance with the authoritative guidance on fair value measurements and disclosures for financial assets and liabilities. This guidance defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. The guidance also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
These tiers include Level 1, defined as observable inputs, such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore, requiring an entity to develop its own assumptions.
The Company’s financial instruments consist principally of cash and cash equivalents, money market funds, accounts receivable, accounts payable, interest rate derivatives, and debt. The carrying value of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value, primarily due to short maturities.
Assets measured at fair value on a recurring basis are summarized below (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Fair Value Measurements at March 31, 2026 |
| | (unaudited) |
| | | Level 1 | | Level 2 | | Level 3 | | Total |
| Assets: | | | | | | | | |
| Cash equivalents - money market funds | | $ | 17,010 | | | $ | — | | | $ | — | | | $ | 17,010 | |
| Interest rate derivatives | | — | | | 105 | | | — | | | 105 | |
| Total | | $ | 17,010 | | | $ | 105 | | | $ | — | | | $ | 17,115 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Fair Value Measurements at December 31, 2025 |
| | |
| | | Level 1 | | Level 2 | | Level 3 | | Total |
| Assets: | | | | | | | | |
| Cash equivalents - money market funds | | $ | 18,551 | | | $ | — | | | $ | — | | | $ | 18,551 | |
| Interest rate derivatives | | — | | | 15 | | | — | | | 15 | |
| Total | | $ | 18,551 | | | $ | 15 | | | $ | — | | | $ | 18,566 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Money market funds included in cash and cash equivalents are highly-liquid investments and are measured at fair value using quoted market prices and active markets, therefore are categorized as Level 1.
The fair value of the Company's interest rate derivatives are measured at the end of each interim reporting period based on the then assessed fair value. As the fair value measure is based on the market approach, they are categorized as Level 2.
The Company believes the carrying value of its long-term debt at March 31, 2026 approximates its fair value based on its variable interest rate feature and interest rates currently available to the Company. The estimated fair value of the Company's debt, before debt discount, at March 31, 2026 and December 31, 2025 was $233.7 million and $238.5 million, respectively, based on valuation methodologies using interest rates currently available to the Company which are Level 2 inputs.
The Company’s non-financial assets, such as property and equipment, goodwill and intangible assets, are recorded at fair value upon a business combination and are remeasured at fair value only if an impairment charge is recognized. The Company uses unobservable inputs to the valuation methodologies that are significant to the fair value measurements, and the valuations require management’s judgment due to the absence of quoted market prices. The Company determines the fair value of its held and used assets, goodwill and intangible assets using an income, cost or market approach as determined reasonable. As the fair value measures are based on unobservable inputs, they are categorized as Level 3.
4. Goodwill and Other Intangible Assets
Changes in the Company’s goodwill balance for the three months ended March 31, 2026 are summarized in the table below (in thousands):
| | | | | | | | | | |
| Balance at December 31, 2025 | | $ | 259,631 | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| Foreign currency translation adjustment | | (1,355) | | | |
| Balance at March 31, 2026 | | $ | 258,276 | | | |
The Company reviews its goodwill for impairment annually in the fourth quarter of the fiscal year and whenever events or changes in circumstances indicate that the carrying value of goodwill might not be recoverable.
Intangible assets, net include the estimated acquisition-date fair values of customer relationships, marketing-related assets, and developed technology that the Company recorded as part of its historical business acquisitions. The following is a summary of the Company’s intangible assets, net (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Estimated Useful Life (Years) | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
| March 31, 2026: | | | |
| Customer relationships | 7-10 | | $ | 200,273 | | | $ | 150,432 | | | $ | 49,841 | |
| Trade name | 9.6-10 | | 1,189 | | | 907 | | | 282 | |
| Developed technology | 4-9 | | 32,021 | | | 26,873 | | | 5,148 | |
| | | | | | | |
| Favorable leases | 6.3 | | 265 | | | 178 | | | 87 | |
| Total intangible assets | | | $ | 233,748 | | | $ | 178,390 | | | $ | 55,358 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Estimated Useful Life (Years) | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
| December 31, 2025: | | | | | | | |
| Customer relationships | 7-10 | | $ | 201,918 | | | $ | 146,221 | | | $ | 55,697 | |
| Trade name | 9.6-10 | | 1,196 | | | 889 | | | 307 | |
| Developed technology | 4-9 | | 32,340 | | | 26,126 | | | 6,214 | |
| | | | | | | |
| Favorable leases | 6.3 | | 270 | | | 171 | | | 99 | |
| Total intangible assets | | | $ | 235,724 | | | $ | 173,407 | | | $ | 62,317 | |
The Company periodically reviews the estimated useful lives of its identifiable intangible assets, taking into consideration any events or circumstances that might result in either a diminished fair value or revised useful life. No impairments of intangibles were recorded during the three months ended March 31, 2026 or the three months ended March 31, 2025.
Total amortization expense was $6.4 million during the three months ended March 31, 2026, and $9.4 million for the three months ended March 31, 2025, respectively.
5. Income Taxes
The Company’s income tax provision for the three months ended March 31, 2026 and March 31, 2025 reflects its estimate of the effective tax rates expected to be applicable for the full years, adjusted for any discrete events that are recorded in the period in which they occur. The estimates are re-evaluated each quarter based on the estimated tax expense for the full year.
The income tax provision of $1.0 million for the three months ended March 31, 2026 is primarily related to the income taxes associated with non-U.S. operations.
The income tax benefit of $1.3 million for the three months ended March 31, 2025 is largely comprised of the tax benefit due to divestitures of businesses during this period. This tax benefit is offset by income taxes associated with U.S. and non-U.S. operations.
The Company historically incurred operating losses in the United States prior to 2021 and given its cumulative losses and limited history of profits, has recorded a valuation allowance against its United States net deferred tax assets at March 31, 2026 and December 31, 2025, respectively.
The Company has reflected uncertain tax positions primarily within its long-term taxes payable and a portion within deferred tax assets for which the balance is immaterial at March 31, 2026. The Company and its subsidiaries file tax returns in the U.S. federal jurisdiction, several U.S. state jurisdictions and several foreign jurisdictions. The Company is no longer subject to U.S. federal income tax examinations for years ending before December 31, 2022 and is no longer subject to state and local or foreign income tax
examinations by tax authorities for years ending before December 31, 2019. U.S. operating losses generated in years prior to 2022 remain open to adjustment until the statute of limitations closes for the tax year in which the net operating losses are utilized.
6. Debt
Long-term debt consisted of the following (in thousands):
| | | | | | | | | | | | | | |
| | | | |
| | March 31, 2026 | | December 31, 2025 |
Senior secured loans (includes unamortized discount and debt costs of $6,006 and $6,094 based on an imputed interest rate of 10.4% and 10.4%, at March 31, 2026 and December 31, 2025, respectively) | | $ | 227,672 | | | $ | 232,406 | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| Less current maturities | | (4,127) | | | (7,739) | |
| Total long-term debt | | $ | 223,545 | | | $ | 224,667 | |
On July 25, 2025, the Company entered into a Credit Agreement (the “Credit Agreement”) which provided for (i) a senior secured term loan facility in the aggregate principal amount of $240.0 million (the “Term Loan”) and (ii) a senior secured revolving credit facility in the aggregate principal amount of $30.0 million (the “Revolving Facility” and together with the Term Loan, the “Credit Facilities”).
The Term Loan matures on July 25, 2031 and bears an interest rate of the secured overnight financing rate, which shall not be less than 1.5%, plus a margin of 6.0% per annum (with step downs and a potential step up at specified leverage levels). At March 31, 2026, the floating interest rate was 9.7%.
Payments on the Term Loan are due quarterly in amounts equal to (a) 2.50% per annum of the original principal amount of the Term Loan commencing beginning December 31, 2025 through September 30, 2026, (b) 1.75% per annum of the original principal amount of the Term Loan commencing December 31, 2026 through September 30, 2027, and (c) 1.00% per annum of the original principal amount of the Term Loan commencing December 31, 2027 and continuing each fiscal quarter thereafter, with the balance payable on the maturity date. Excess Cash Flow payments due under the terms of the Credit Agreement were $0.2 million and $3.3 million at March 31, 2026 and December 31, 2025, respectively, and are included in current maturities of long-term debt in the condensed consolidated balance sheets.
The Revolving Facility matures on July 25, 2031 and bears the same interest rate as the Term Loan. No amounts were outstanding under the Revolving Facility as of March 31, 2026.
The Credit Facilities contains customary representations, warranties, covenants, including financial covenant, and events of default. The Credit Facilities are secured by substantially all of the Company’s assets, subject to certain exclusions. The Term Loan also includes (i) a covenant tested quarterly which limits the consolidated secured leverage ratio to 6.0 to 1.0 or under and (ii) certain other changes to the terms of the Credit Agreement, including with respect to certain negative covenants. The Revolving Facility is subject to the same covenants and terms as the Term Loan. As of March 31, 2026, the Company was in compliance with all covenants under the Credit Facilities.
The Company’s previous senior secured credit agreement provided for 7 year, senior secured term loans which were repaid July 25, 2025 with the proceeds of the Term Loan.
Lender fees and third party costs associated with the Term Loan are recorded as a direct deduction from the long-term debt and lender fees and third party costs associated with the Revolving Facility are recorded in other assets in the condensed consolidated balance sheets. All lender fees and third party costs are amortized into interest expense, net over the contractual term of the Credit Agreement.
Interest rate derivatives
In 2019 the Company entered into floating-to-fixed interest rate swap agreements to limit exposure to interest rate risk related to their debt through the maturity of the previous senior secured term loans, August 6, 2026. At the time the Company entered into the interest rate swap agreements, the Company designated all of the swaps as cash flow hedges. In August 2024, the Company de-designated all of the interest rate swaps and the realized and unrealized gains previously recognized as a component of accumulated other comprehensive loss are being amortized to interest expense, net as interest is accrued or prepayments are made on the Company’s debt. Subsequent to the de-designation, changes in the fair value of the interest rate swaps were recorded to interest expense, net. On July 18, 2025, the Company sold all of its remaining floating-to-fixed interest rate swap agreements.
Effective September 30, 2025, the Company entered into an interest rate cap agreement to limit exposure to interest rate risk, effectively capping the secured overnight financing rate at 4.5% related to $120.0 million of their outstanding debt. The interest rate cap is reported at fair value and is included in interest rate derivatives on the condensed consolidated balance sheets, and the change in the fair value of the interest rate cap is reported in interest expense, net on the condensed consolidated statements of operations.
The impact of the Company’s interest rate swaps on its condensed consolidated statements of comprehensive loss for the three months ended March 31, 2026 and March 31, 2025 was as follows (in thousands):
| | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | | | |
| | | | | | | | |
Amounts reclassified from accumulated other comprehensive loss to interest expense, net | | $ | (1,137) | | | $ | (3,890) | | | | | |
| | | | | | | | |
The impact of the Company’s interest rate derivatives on its condensed consolidated statements of operations for the three months ended March 31, 2026 and March 31, 2025 was as follows (in thousands):
| | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | | | |
Unrealized gain (loss) in fair value of interest rate derivatives | | $ | 90 | | | $ | (2,164) | | | | | |
Amounts reclassified from accumulated other comprehensive loss to interest expense, net | | 1,137 | | | 3,890 | | | | | |
Cash payments on interest rate swaps | | — | | | 1,663 | | | | | |
Total income (expense) from interest rate derivatives in interest expense, net | | $ | 1,227 | | | $ | 3,389 | | | | | |
Cash interest costs averaged 9.7% and 5.9% for the three months ended March 31, 2026 and 2025, respectively.
7. Net Loss Per Share
The Company computes net loss per share of common stock, par value $0.0001 per share (“Common Stock”) and Series A Preferred Stock, par value $0.0001 per share (“Series A Preferred Stock”) using the two-class method. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considers its Series A Preferred Stock to be a participating security, as its holders are entitled to fully participate in any dividends or other distributions declared or paid on its Common Stock on an as-converted basis.
The following table sets forth the computations of net loss per share (in thousands, except share and per share amounts):
| | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | | | |
| | | | | | | | |
| Numerator: | | | | | | | | |
| Net Loss | | $ | (1,230) | | | $ | (25,848) | | | | | |
| | | | | | | | |
| Preferred stock dividends and accretion | | (1,503) | | | (1,438) | | | | | |
| Net loss attributable to common stockholders | | $ | (2,733) | | | $ | (27,286) | | | | | |
| Denominator: | | | | | | | | |
| Weighted–average common shares outstanding, basic and diluted | | 29,159,015 | | | 28,220,936 | | | | | |
| Net loss per common share, basic and diluted | | $ | (0.09) | | | $ | (0.97) | | | | | |
| | | | | | | | |
| | | | | | | | |
Due to the net losses for the three months ended March 31, 2026 and March 31, 2025, respectively, basic and diluted net loss per share were the same. The Company uses the application of the if-converted method for calculating diluted earnings per share on its Series A Preferred Stock. The Company applies the treasury stock method for calculating diluted earnings per share on its stock options, restricted stock units and performance-based restricted stock units.
Contingently issuable shares associated with outstanding performance-based restricted stock units (each, a “PSU”) were not included in the basic earnings per share calculations for the periods presented, as the applicable vesting conditions had not been satisfied.
Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows:
| | | | | | | | | | | | | | |
| | | March 31, |
| | | 2026 | | 2025 |
| | | | |
| Stock options | | 71,632 | | | 103,561 | |
| | | | |
Restricted stock units | | 2,081,670 | | | 2,679,178 | |
| Performance restricted stock units | | 250,000 | | | 350,000 | |
Series A Preferred Stock on an if-converted basis(1) | | 7,722,133 | | | 7,384,195 | |
| Total anti–dilutive common share equivalents | | 10,125,435 | | | 10,516,934 | |
(1) As of March 31, 2026, the Series A Preferred Stock plus accumulated dividends totaled $135.1 million. The Series A Preferred Stock has a conversion price of $17.50 per share, as detailed in “Note 9. Mezzanine Equity”.
8. Commitments and Contingencies
Purchase Commitments
The Company has purchase commitments related to hosting services, third-party technology used in the Company's solutions and for other services the Company purchases as part of normal operations. In certain cases these arrangements require a minimum annual purchase commitment.
Litigation
In the normal course of business, the Company is involved in various lawsuits and legal proceedings. The Company does not anticipate that any current or pending legal proceedings will have a material adverse effect on the Company's condensed consolidated balance sheets or condensed consolidated statements of operations.
Letter of Credit
In conjunction with an operating lease agreement, the Company provided a $0.6 million letter of credit in conformance with the contractual provisions of the lease. The letter of credit expires July 2029. The amount underlying such letter of credit is reflected as restricted cash in the Company's consolidated balance sheets as of March 31, 2026.
9. Mezzanine Equity
Series A Convertible Preferred Stock
As of March 31, 2026 and December 31, 2025, there were 115,000 shares of Series A Preferred Stock of the Company, par value $0.0001 per share, issued and outstanding. The Series A Preferred Stock was issued on August 23, 2022 for an aggregate purchase price $115.0 million. In connection with the issuance of the Series A Preferred Stock, the Company incurred direct and incremental expenses of $4.6 million comprised of transaction fees, and financial advisory and legal expenses which reduced the carrying value of the Series A Preferred Stock. Holders of the Series A Preferred Stock have certain customary registration rights with respect to any shares of Series A Preferred Stock or the Common Stock of the Company issuable upon conversion of the Series A Preferred Stock, including rights with respect to the filing of a shelf registration statement, underwritten offering rights and piggy back rights.
Dividend Provisions
The Series A Preferred Stock ranks senior to the Company’s Common Stock with respect to payment of dividends and rights on the distribution of assets on any liquidation, dissolution or winding up of the affairs of the Company. The Series A Preferred Stock has an Initial Liquidation Preference of $1,000 per share, representing an aggregate Liquidation Preference (as defined below) of $1,000 upon issuance. Holders of the Series A Preferred Stock are entitled to the dividend at the rate of 4.5% per annum, within the first seven years after August 23, 2022 regardless of whether declared or assets are legally available for the payment. Such dividends shall accrue and compound quarterly in arrears from the date of issuance of the shares. The dividend rate will increase to 7.0% on the seven-year anniversary of August 23, 2022. The dividend can be paid, in the Company’s sole discretion, in cash or dividend in kind by adding to the Liquidation Preference of each share of Series A Preferred Stock outstanding. On June 7, 2023, the stockholders of the Company authorized, for purposes of complying with Nasdaq Listing Rules 5635(b) and (d), the issuance of shares of Common Stock underlying shares of Series A Preferred Stock in an amount equal to or in excess of 20% of the Common Stock outstanding immediately prior to the issuance of such Series A Preferred Stock (including upon the operation of anti-dilution provisions contained
in the Certificate of Designation designating the terms of such Series A Preferred Stock). The Series A Preferred Stock is also entitled to fully participate in any dividends paid to the holders of Common Stock in cash, in stock or otherwise, on an as-converted basis. The Series A Preferred Stock had accrued unpaid dividends of $20.1 million as of March 31, 2026, representing 1,150,705 Common Stock shares upon conversion at $17.50 per share.
Liquidation Rights
In the event of any Liquidation, holders of the Series A Preferred Stock are entitled to receive an amount per share equal to the greater of (1) the Initial Liquidation Preference per share plus any accrued or declared but unpaid dividends on such shares (the “Liquidation Preference”) or (2) the amount payable if the Series A Preferred Stock were converted into Common Stock. The Series A Preferred Stock will have distribution and liquidation rights senior to all other equity interests of the Company. As of March 31, 2026, the Liquidation Preference of the Series A Preferred Stock plus accrued and unpaid dividends was $135.1 million.
Optional Redemption
On or after the 7th anniversary of the original issue date of the Series A Preferred Stock, the Company has the right to redeem any outstanding shares of the Series A Preferred Stock for a cash purchase price equal to 105% of the Liquidation Preference plus accrued and unpaid dividends as of the date of redemption.
Deemed Liquidation Event Redemption
Upon a fundamental change, holders of the Series A Preferred Stock have the right to require the Company to repurchase any or all of its Series A Preferred Stock for cash equal to the greater of (1) 105% of the Liquidation Preference plus the present value of the dividend payments the holders would have been entitled to through the fifth anniversary of the issue date and (2) the amount that such Preferred Stock would have been entitled to receive as if converted into common shares immediately prior to the fundamental change.
A fundamental change (“Deemed Liquidation Event”) is defined as either the direct or indirect sale, lease, transfer, conveyance or other disposition of all or substantially all the properties or assets of the Company and its subsidiaries to any third party or the consummation of any transaction, the result of which is that any third party or group of third parties become the beneficial owner of more than 50% of the voting power of the Company.
Voting Rights
The Series A Preferred Stock will vote together with the common shares on all matters and not as a separate class (except as specifically provided in the Certificate of Designation or as otherwise required by law) on an as-converted basis. The holders of the Series A Preferred Stock will have the right to elect one member of the Board of Directors of the Company (the “Board of Directors”) for so long as holders of the Series A Preferred Stock own in the aggregate at least 5% of the shares of Common Stock on a fully diluted basis. In addition, the holders of the Series A Preferred Stock will have the right to elect one non-voting observer to the Board of Directors for so long as they hold at least 10% of the shares of Convertible Preferred Stock outstanding as of the date of the issue date.
Conversion Feature
The Series A Preferred Stock may be converted, at any time in whole or in part at the option of the holder into a number of shares of Common Stock equal to the quotient obtained by dividing the sum of the Liquidation Preference plus all accrued and unpaid dividends by the conversion price of $17.50 (the “Conversion Price”). The Conversion Price is subject to adjustment in certain events.
Anti-Dilution Provisions
The Series A Preferred Stock has customary anti-dilution provisions for stock splits, stock dividends, mergers, sales of significant assets, and reorganization events and recapitalization transactions or similar events, and weighted average anti-dilution protection, subject to customary exceptions for issuances pursuant to current or future equity-based incentive plans or arrangements (including upon the exercise of employee stock options).
10. Stockholders' Deficit
Common Stock
The common stock has a par value of $0.0001 per share. Each share of common stock is entitled to one vote at all meetings of stockholders. The number of authorized shares of common stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of shares of capital stock of the Company representing a majority of the votes represented by all outstanding shares of capital stock of the Company entitled to vote. The holders of common stock are also entitled to receive dividends, when, if and as declared by the board of directors, whenever funds are legally available therefore, subject to the priority rights of any outstanding preferred stock.
Share Repurchase Programs
On August 15, 2025, the Board of Directors authorized a stock repurchase program (the “2025 Share Repurchase Plan”) in the aggregate amount of up to $10 million (inclusive of any taxes payable as a result of such repurchase) that would allow the Company to repurchase shares of its issued and outstanding common stock, par value $0.0001 per share. The authorization does not have a specified expiration date. Accordingly, unless terminated earlier by resolution of the Board, the 2025 Share Repurchase Plan will expire when the Company has repurchased all shares authorized for repurchase thereunder. The Company is not obligated to acquire any particular amount of Common Stock and may modify or suspend the repurchases at any time in the Company’s discretion.
In the three months ended March 31, 2026, the Company did not purchase shares as part of the 2025 Stock Repurchase Plan. As of March 31, 2026, $9.9 million was still available for share repurchases under the 2025 Share Repurchase Plan.
Tax Benefit Preservation Plan and Preferred Stock Purchase Rights
Effective June 5, 2024, the Company entered into the 2024 Tax Benefit Preservation Plan with Broadridge Corporate Issuer Solutions, LLC, as Rights Agent (the “2024 Tax Benefit Preservation Plan”). By adopting the 2024 Tax Benefit Preservation Plan, the Company is seeking to protect its ability to use its net operating loss carryforwards (“NOLs”) and other tax attributes to offset potential future income tax liabilities. The Company’s ability to use such NOLs and other tax attributes would be substantially limited if the Company experiences an “ownership change,” as defined in Section 382 of the Internal Revenue Code. The 2024 Tax Benefit Preservation Plan is intended to make it more difficult for the Company to undergo an ownership change by deterring any person from acquiring 4.9% or more of the outstanding shares of stock without the approval of the Board of Directors.
As part of the 2024 Tax Benefit Preservation Plan, the Board declared a dividend of one preferred stock purchase right (a “2024 Right” and collectively the “2024 Rights”) for each outstanding share of Common Stock payable as of June 15, 2024. In connection with the 2024 Tax Benefit Preservation Plan, 27,030,605 2024 Rights were issued. The description and terms of the 2024 Rights are set forth in the 2024 Tax Benefit Preservation Plan. The 2024 Rights trade with, and are inseparable from, the Common Stock, and the record holders of shares of Common Stock are the record holders of the 2024 Rights. The 2024 Rights are not exercisable until the Distribution Date, as defined in the 2024 Tax Benefit Preservation Plan.
After the Distribution Date, each 2024 Right will be exercisable to purchase from the Company one one-thousandth of a share of Series B Junior Participating Preferred Stock, par value $0.0001 per share, of the Company (the “Series B Preferred”), at a purchase price of $15.25 per one one-thousandth of a share of Series B Preferred, subject to adjustment as provided in the 2024 Tax Benefit Preservation Plan. Until a 2024 Right is exercised or exchanged, the holder thereof, as such, will have no rights as a stockholder of the Company by virtue of holding such Right, including, without limitation, the right to vote and to receive dividends. The Board may adjust the Purchase Price, the number of shares of Series B Preferred issuable and the number of outstanding 2024 Rights to prevent dilution that may occur from a stock dividend, a stock split, a reclassification of the Series B Preferred or Common Stock or certain other specified transactions. No adjustments to the Purchase Price of less than 1% are required to be made.
Each one one-thousandth of a share of Series B Preferred, if issued:
•Will not be redeemable.
•Will entitle holders to quarterly dividend payments of $0.001 per one one-thousandth of a share of Series B Preferred, or an amount equal to the dividend paid on one share of Common Stock, whichever is greater.
•Will entitle holders upon liquidation either to receive $0.001 per one one-thousandth of a share of Series B Preferred, or an amount equal to the payment made on one share of Common Stock, whichever is greater.
•Will have the same voting power as one share of Common Stock.
•If shares of Common Stock are exchanged as a result of a merger, consolidation, or a similar transaction, will entitle holders to a per share payment equal to the payment made on one share of Common Stock.
Accumulated Other Comprehensive Income (Loss)
Comprehensive income consists of two elements, net loss and other comprehensive income (loss). Other comprehensive income (loss) items are recorded in the stockholders’ deficit section of the condensed consolidated balance sheets and are excluded from net loss. Other comprehensive income consists primarily of unrealized foreign currency translation adjustments for subsidiaries with functional currencies other than the U.S. dollar, unrealized translation gains (losses) on intercompany loans with foreign subsidiaries when repayment of those loans is not anticipated in the foreseeable future, and gains (losses) on interest rate swaps, net of amounts reclassified into interest expense, net.
The following table shows the components of accumulated other comprehensive loss, net of income taxes, (“AOCI”) in the stockholders’ deficit section of the condensed consolidated balance sheets at the dates indicated (in thousands):
| | | | | | | | | | | | | | |
| | March 31, 2026 | | December 31, 2025 |
| Unrealized foreign currency translation adjustment, net of realized amounts reclassified into loss from divestitures of businesses | | $ | (16,331) | | | $ | (15,223) | |
| | | | |
| Unrealized translation losses on intercompany loans with foreign subsidiaries, net of taxes | | (2,534) | | | (2,605) | |
| Unrealized gains on interest rate swaps, net of amounts reclassified into interest expense, net | | 1,553 | | | 2,690 | |
| | | | |
| Total accumulated other comprehensive loss | | $ | (17,312) | | | $ | (15,138) | |
The unrealized translation losses on intercompany loans considered long-term in nature with foreign subsidiaries as of March 31, 2026 and December 31, 2025 are net of income tax of $1.4 million and $1.5 million, respectively.
The functional currency of foreign subsidiaries are the local currencies. Results of operations for foreign subsidiaries are translated into United States dollars (“USD”) using the average exchange rates on a monthly basis during the year. The assets and liabilities of those subsidiaries are translated into USD using the exchange rates in effect at the balance sheet date. The related translation adjustments are recorded in a separate component of stockholders' deficit in AOCI.
The income tax expense/benefit allocated to each component of other comprehensive income for all periods and components is not material. The Company reclassifies taxes from AOCI to earnings as the items to which the tax effects relate are similarly reclassified.
Stock-Based Compensation
The Company’s stock-based compensation generally includes awards of restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”). Key employees, officers and directors of the Company and its consultants or advisors are eligible to receive awards.
The following table summarizes PSU and RSU activity during the three months ended March 31, 2026: | | | | | | | | | | | | | | |
| | Number of Units | | Weighted-Average Grant Date Fair Value |
| Unvested restricted units outstanding as of December 31, 2025 | | 1,949,383 | | | $ | 4.88 | |
| Granted | | 935,000 | | | 0.94 | |
| Vested | | (382,294) | | | 3.86 | |
| Forfeited | | (170,419) | | | 3.50 | |
| Unvested restricted units outstanding as of March 31, 2026 | | 2,331,670 | | | $ | 3.57 | |
The PSU and RSU activity table above includes 250,000 PSUs granted in 2025 based on a 100% target payout and still outstanding at March 31, 2026.
Compensation cost related to awards is based on the fair market value at the time of the grant. The fair value of the RSUs is determined based on the grant date fair value of the award. Compensation expense for RSUs is recognized over the required service period of the grant. The PSUs vest upon the achievement of specified market performance thresholds. The PSUs have a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance up to a maximum of 300%, depending on the specified performance condition and the level of achievement obtained. The fair value of PSUs is determined using the Monte Carlo simulation model. Compensation expense for PSUs is recognized over the requisite service period and is not subject to adjustment regardless of whether the PSUs meet the performance metric.
The Company recognizes stock-based compensation expense from all awards in the following expense categories included in the condensed consolidated statements of income (in thousands):
| | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | | | |
| Cost of revenue | | $ | 86 | | | $ | 121 | | | | | |
| Research and development | | 83 | | | 290 | | | | | |
| Sales and marketing | | 30 | | | 252 | | | | | |
| General and administrative | | 762 | | | 2,012 | | | | | |
| Total | | $ | 961 | | | $ | 2,675 | | | | | |
11. Revenue Recognition
Deferred Commissions
Sales commissions earned by our sales force, and related payroll taxes, are considered incremental and recoverable costs of obtaining a contract with a customer. Deferred commissions and other costs for new customer contracts are capitalized upon contract signing and amortized on a systematic basis that is consistent with the transfer of goods and services over the expected life of the customer relationships, which has been determined to be approximately 6 years. Commissions paid on renewal contracts are not commensurate with commissions paid on new customer contracts, as such, deferred commissions related to renewals are capitalized and amortized over the estimated average contractual renewal term of 18 months. Amortization expense is included in sales and marketing expenses in the accompanying condensed consolidated statements of operations. Deferred commissions are reviewed for impairment whenever events or circumstances indicate their carrying value may not be recoverable consistent with the Company's long-lived assets policy. No indicators of impairment were identified during the three months ended March 31, 2026.
Amortization of deferred commissions in excess of commissions capitalized for the three months ended March 31, 2026 the three months ended March 31, 2025 was $0.2 million and $0.7 million, respectively.
Deferred Revenue
Deferred revenue represents either customer advance payments or billings for which the aforementioned revenue recognition criteria have not yet been met.
Deferred revenue is mainly unearned revenue related to subscription services and support services. During the three months ended March 31, 2026, we recognized $30.9 million and $0.6 million of subscription services and professional services revenue, respectively, that was included in the deferred revenue balances at the beginning of the period.
Remaining Performance Obligations
As of March 31, 2026, approximately $165.2 million of revenue is expected to be recognized from remaining performance obligations. We expect to recognize revenue on approximately 68% of these remaining performance obligations over the next 12 months, with the balance recognized thereafter.
12. Divestitures
During the three months ended March 31, 2026, the Company did not execute any divestitures. Proceeds for divestitures completed in 2025 included a secured promissory note in the original principal amount of $5.5 million to be repaid quarterly over 5 years bearing interest at 10% annually through maturity in July 2030. At March 31, 2026, the book value of the note receivable was $2.8 million including a reserve for potential credit loss. The Company monitors the collectability of the note and will record adjustments to the estimated net realizable value as deemed necessary until the note is settled. At March 31, 2026, the current portion of the promissory note less associated reserve was $0.8 million and is recorded in prepaid and other current assets on the Company’s condensed consolidated balance sheets and the long-term portion of the promissory note less associated reserve was $3.6 million and is recorded in other assets on the Company’s condensed consolidated balance sheets.
The Company's interest in this note receivable is a variable interest and the underlying entity is a variable interest entity (“VIE”). The Company is not the primary beneficiary of this VIE because the Company does not individually have the power to direct the activities that are most significant to the entity and accordingly, the VIE is not consolidated.
As part of the divestitures, the Company entered into a transition services agreement (“TSA”) with the buyers to assist them in the transition of certain functions, including, but not limited to, information technology, finance and accounting, for an initial period of 60-120 days unless extended by mutual agreement. As of March 31, 2026 and March 31, 2025, the Company has $0.2 million and $2.0 million, respectively, in TSA receivables and escrow due from the buyers recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.
During the three months ended March 31, 2025, the Company completed the divestitures of certain product lines for combined consideration of $5.5 million and up to $4.0 million in earn-outs over 2 years. The combined net loss on divestitures was $23.5 million for the three months ended March 31, 2025. The Company incurred divestiture-related expenses of $1.7 million during the three months ended March 31, 2025 which are recorded in divestiture-related expenses on the Company’s condensed consolidated statements of operations.
13. Segment Information
The Company’s Chief Executive Officer is considered to be the Company’s chief operating decision-maker (“CODM”). The CODM manages the business as a multi-product cloud-based software application business that utilizes a singular operating model to deliver a
consistently high level of operating performance to customers regardless of their geography or IT environment. Operating results are reviewed by the CODM primarily at the consolidated entity level for purposes of making resource allocation decisions and for evaluating financial performance. Accordingly, the Company has determined that it is a single operating and reporting segment structure. The key measure of profit or loss utilized by the CODM to assess performance of and allocate resources within the Company’s single operating segment is net loss. This measure is presented on the condensed consolidated statements of operations. Significant segment expenses included in net loss are cost of revenue, sales and marketing expenses, research and development expenses, general and administrative expenses, depreciation and amortization, interest expense, net and other income (expense), which are presented on the condensed consolidated statements of operations. The measure of segment assets is reported on the condensed consolidated balance sheets as total assets.
14. Subsequent Events
As previously disclosed by the Company in its Current Report on Form 8-K filed with the SEC on April 10, 2026, on April 7, 2026, the Company received a notification letter (the “Deficiency Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (Rule “5450(a)(1)”). The Deficiency Notice is a notice of deficiency, not delisting, and does not currently affect the listing or trading of the Company’s common stock on the Nasdaq Global Market. The Company's common stock will continue to trade on the Nasdaq Global Market under the symbol “UPLD” at this time.
The Company intends to actively monitor the closing bid price of its common stock and to consider plans for regaining compliance with Rule 5450(a)(1). While the Company plans to review all available options, there can be no assurance that it will be able to regain compliance with the applicable rules during the 180-day compliance period ending on October 5, 2026, any additional compliance period, or at all.
Additional information regarding the Deficiency Notice can be found in the Company’s Current Report on Form 8-K filed with the SEC on April 10, 2026.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward Looking Statements
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q and our other filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2025. In addition to historical information, this Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “may,” “will,” “continue,” “seek,” “estimate,” “intend,” “hope,” “predict,” “could,” “should,” “would,” “project,” “plan,” “expect” or the negative or plural of these words or similar expressions, although not all forward-looking statements contain these words.
You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors, including those described in the section titled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.
The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.
Overview
Upland Software, Inc. is a leader in AI-powered knowledge and content management software. Our solutions help enterprises unlock critical knowledge, automate content workflows, and drive measurable ROI—enhancing customer and employee experiences while supporting regulatory compliance. More than 1,100 enterprise customers rely on Upland to solve complex challenges and provide a trusted path for AI adoption.
Key Metrics and Non-GAAP Financial Measures
In addition to the GAAP financial measures described below in “Results of Operations,” we regularly review the following key metrics and non-GAAP financial measures to evaluate and identify trends in our business, measure our performance, prepare financial projections and make strategic decisions.
Core Organic Growth Rate
We use Core Organic Growth Rate as a key performance measure to assess our consolidated operating performance over time and for planning and forecasting purposes. Core Organic Growth Rate is the percentage change between two reported periods in subscription and support revenue, excluding subscription and support revenue from Sunset Assets, subscription and support revenue from divestitures, and Overage Charges, each as defined below. We calculate our year-over-year Core Organic Growth Rate as though all acquisitions or dispositions closed as of the end of the latest period were closed as of the first day of the prior year period presented. Core Organic Growth Rate does not represent actual organic revenue generated by our business as it stood at the beginning of the respective period.
For the three-month period ended March 31, 2026, our Core Organic Growth Rate was 0.25%.
Core Organic Growth Rates are not necessarily indicative of either future results of operations or actual results that might have been achieved had certain Sunset Asset classifications not been made or had certain acquisitions or dispositions been consummated on the first day of the prior year period presented. We believe that this metric is useful to management and investors in analyzing our financial and operational performance period-over-period along with evaluating the growth of our business normalized for the impact of acquisitions and dispositions, as well as adjusting for the exclusion of non-core Sunset Assets and non-committed Overage Charges.
Related Defined Terms
In connection with periodic reviews of our business, we have decided to discontinue the availability of certain non-strategic product offerings and a limited number of non-strategic customer contracts (collectively referred to as “Sunset Assets”). It is possible that during future periodic reviews of our business we may determine to add additional non-strategic product offerings or non-strategic customer contracts to Sunset Assets or remove certain product offerings or customer contracts from the classification of Sunset Assets. In either case, we will adjust the revenues attributable to Sunset Assets and properly reflect the year over year change for such addition or removal.
Overage Charges are subscription and support revenues earned in addition to contractual minimum customer commitments as a result of the usage volume of services including text and e-mail messaging and third-party pass-through costs that exceed the levels stipulated in contracts with the Company.
The following table represents a reconciliation of total revenue, the most comparable GAAP measure, to core organic revenue for each of the periods indicated.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2026 | | 2025 | | | | |
| | | | | | | |
| (dollars in thousands) |
| Reconciliation of total revenue to core organic revenue: | | | | | | |
| Total revenue | $ | 48,690 | | | $ | 63,655 | | | | | |
| Less: | | | | | | | |
| Perpetual license revenue | 1,295 | | | 1,608 | | | | | |
| Professional services revenue | 1,304 | | | 1,865 | | | | | |
| Subscription and support revenue from Sunset Assets | 1,901 | | | 2,368 | | | | | |
| Subscription and support revenue from divestitures | — | | | 12,433 | | | | | |
| Overage Charges | 27 | | | 1,328 | | | | | |
| Core organic revenue | $ | 44,163 | | | $ | 44,053 | | | | | |
Adjusted EBITDA
We monitor our Adjusted EBITDA to help us evaluate the effectiveness and efficiency of our operations. Adjusted EBITDA is a non-GAAP financial measure. We define Adjusted EBITDA as net income (loss), calculated in accordance with GAAP, adjusted for depreciation and amortization expense, net interest expense, loss on debt extinguishment, net other expense (income), benefit from (provision for) income taxes, stock-based compensation expense, acquisition and divestiture related expense, purchase accounting deferred revenue discount, gains and losses on divestitures of businesses, and impairment charges.
The following table represents a reconciliation of net loss from continuing operations, the most comparable GAAP measure, to Adjusted EBITDA for each of the periods indicated.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2026 | | 2025 | | | | |
| | | | | | | |
| (dollars in thousands) |
| Reconciliation of Net Loss to Adjusted EBITDA: | | | | |
| Net loss | $ | (1,230) | | | $ | (25,848) | | | | | |
| Add: | | | | | | | |
| | | | | | | |
| Depreciation and amortization expense | 6,624 | | | 9,661 | | | | | |
| Interest expense (income), net | 4,459 | | | 2,443 | | | | | |
| | | | | | | |
| Other expense (income), net | 834 | | | 241 | | | | | |
| Provision for (benefit from) income taxes | 986 | | | (1,345) | | | | | |
| Stock-based compensation expense | 961 | | | 2,675 | | | | | |
| Divestiture-related expenses | 22 | | | 1,745 | | | | | |
| | | | | | | |
| Non-recurring litigation costs | 1 | | | 18 | | | | | |
| Purchase accounting deferred revenue discount | 13 | | | 35 | | | | | |
| Loss on divestitures of businesses | — | | | 23,457 | | | | | |
| | | | | | | |
| Adjusted EBITDA | $ | 12,670 | | | $ | 13,082 | | | | | |
We believe that Adjusted EBITDA provides useful information to management, investors and others in understanding and evaluating our operating results for the following reasons:
•Adjusted EBITDA is widely used by investors and securities analysts to measure a company’s operating performance without regard to items that can vary substantially from company to company depending upon their financing, capital structures and the method by which assets were acquired;
•Our management uses Adjusted EBITDA in conjunction with GAAP financial measures for planning purposes, in the preparation of our annual operating budget, as a measure of our operating performance, to assess the effectiveness of our business strategies and to communicate with our board of directors concerning our financial performance because Adjusted EBITDA eliminates the impact of items that we do not consider indicative of our core operating performance;
•Adjusted EBITDA provides more consistency and comparability with our past financial performance, facilitates period-to-period comparisons of our operations and also facilitates comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results.
Adjusted EBITDA should not be considered as an alternative to net loss or any other measure of financial performance calculated and presented in accordance with GAAP. The use of Adjusted EBITDA as an analytical tool has limitations such as:
•Impairment of goodwill and other intangibles and depreciation and amortization are non-cash charges, and the assets being depreciated or amortized, which contribute to the generation of revenue, will often have to be replaced in the future and Adjusted EBITDA does not reflect cash requirements for such replacements; however, much of the depreciation and amortization relates to amortization of acquired intangible assets as well as the goodwill as a result of business combination purchase accounting adjustments, which will not need to be replaced in the future;
•Adjusted EBITDA may not reflect changes in, or cash requirements for, our working capital needs or contractual commitments;
•Adjusted EBITDA does not reflect the potentially dilutive impact of stock-based compensation;
•Adjusted EBITDA does not reflect interest or tax payments that could reduce cash available for use; and
•Other companies, including companies in our industry, might calculate Adjusted EBITDA or similarly titled measures differently, which reduces their usefulness as comparative measures.
Because of these limitations, you should consider Adjusted EBITDA together with other financial performance measures, including various cash flow metrics, net loss and our other GAAP results.
Results of Operations
Consolidated Statements of Operations Data
The following table set forth our results of operations for the specified periods, as well as our results of operations for the specified periods as a percentage of revenue. The period-to-period comparisons of results of operations are not necessarily indicative of results for future periods.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | | | |
| | Amount | | Percent of Revenue | | Amount | | Percent of Revenue | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | (dollars in thousands, except share and per share data) |
| Revenue: | | | | | | | | | | | | | | | | |
| Subscription and support | | $ | 46,091 | | | 95 | % | | $ | 60,182 | | | 95 | % | | | | | | | | |
| Perpetual license | | 1,295 | | | 3 | % | | 1,608 | | | 3 | % | | | | | | | | |
| Total product revenue | | 47,386 | | | 98 | % | | 61,790 | | | 98 | % | | | | | | | | |
| Professional services | | 1,304 | | | 2 | % | | 1,865 | | | 2 | % | | | | | | | | |
| Total revenue | | 48,690 | | | 100 | % | | 63,655 | | | 100 | % | | | | | | | | |
| Cost of revenue: | | | | | | | | | | | | | | | | |
Subscription and support (1)(3) | | 11,112 | | | 23 | % | | 16,950 | | | 27 | % | | | | | | | | |
Professional services and other (1) | | 822 | | | 2 | % | | 1,098 | | | 1 | % | | | | | | | | |
| Total cost of revenue | | 11,934 | | | 25 | % | | 18,048 | | | 28 | % | | | | | | | | |
| Gross profit | | 36,756 | | | 75 | % | | 45,607 | | | 72 | % | | | | | | | | |
| Operating expenses: | | | | | | | | | | | | | | | | |
Sales and marketing (1) | | 9,472 | | | 19 | % | | 13,756 | | | 22 | % | | | | | | | | |
Research and development (1) | | 8,044 | | | 16 | % | | 11,542 | | | 18 | % | | | | | | | | |
| | | | | | | | | | | | | | | | |
General and administrative (1)(2) | | 8,538 | | | 18 | % | | 11,621 | | | 18 | % | | | | | | | | |
| Depreciation and amortization | | 5,631 | | | 12 | % | | 7,995 | | | 13 | % | | | | | | | | |
| Divestiture-related expenses | | 22 | | | — | % | | 1,745 | | | 2 | % | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Total operating expenses | | 31,707 | | | 65 | % | | 46,659 | | | 73 | % | | | | | | | | |
| Income (loss) from operations | | 5,049 | | | 10 | % | | (1,052) | | | (1) | % | | | | | | | | |
| Other expense: | | | | | | | | | | | | | | | | |
| Interest expense, net | | (4,459) | | | (9) | % | | (2,443) | | | (4) | % | | | | | | | | |
| Loss on divestitures of businesses | | — | | | — | % | | (23,457) | | | (37) | % | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Other income (expense), net | | (834) | | | (2) | % | | (241) | | | — | % | | | | | | | | |
| Total other expense | | (5,293) | | | (11) | % | | (26,141) | | | (41) | % | | | | | | | | |
| Loss before benefit from (provision for) income taxes | | (244) | | | (1) | % | | (27,193) | | | (42) | % | | | | | | | | |
| Benefit from (provision for) income taxes | | (986) | | | (2) | % | | 1,345 | | | 1 | % | | | | | | | | |
| Loss from operations | | (1,230) | | | (3) | % | | (25,848) | | | (41) | % | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Preferred stock dividends and accretion | | (1,503) | | | (3) | % | | (1,438) | | | (2) | % | | | | | | | | |
| Net loss attributable to common shareholders | | $ | (2,733) | | | (6) | % | | $ | (27,286) | | | (43) | % | | | | | | | | |
| Net loss per common share: | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Net loss per common share, basic and diluted | | $ | (0.09) | | | | | $ | (0.97) | | | | | | | | | | | |
| Weighted-average common shares outstanding, basic and diluted | | 29,159,015 | | | | | 28,220,936 | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
(1) Includes stock-based compensation detailed under Share-based Compensation in “Item 1. Financial Statements—Note 10. Stockholders' Deficit”. |
|
(2) Includes general and administrative stock-based compensation of $0.8 million and $2.0 million for the three months ended March 31, 2026 and March 31, 2025, respectively. General and administrative expense excluding stock-based compensation as a percentage of total revenues was 16% and 15% for the three months ended March 31, 2026 and March 31, 2025, respectively. |
| | | | | | | | | | | | | | | | |
|
(3) Includes depreciation and amortization of $1.0 million and $1.7 million for the three months ended March 31, 2026 and March 31, 2025, respectively. |
Comparison of the Three Months Ended March 31, 2026 and 2025
See Note 12. Divestitures regarding product lines divested in the three months ended March 31, 2025.
Revenue | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
| Revenue: | | | | | | | | | | | | |
| Subscription and support | | $ | 46,091 | | $ | 60,182 | | (23) | % | | | | | | |
| Perpetual license | | 1,295 | | 1,608 | | (19) | % | | | | | | |
| Total product revenue | | 47,386 | | 61,790 | | (23) | % | | | | | | |
| Professional services | | 1,304 | | 1,865 | | (30) | % | | | | | | |
| Total revenue | | $ | 48,690 | | $ | 63,655 | | (24) | % | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
For the Three Months Ended March 31, 2026
Total revenue was $48.7 million in the three months ended March 31, 2026, compared to $63.7 million in the three months ended March 31, 2025, a decrease of $15.0 million, or 24%. This decrease is primarily due to the expected declines in revenue related to divested product lines of $14.0 million and Sunset Assets of $0.5 million. Declines in perpetual license revenue of $0.3 million and professional services revenue of $0.3 million in core products were partially offset by an increase in subscription and support revenue of $0.1 million related to core products.
Cost of Revenue
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
| Cost of revenue: | | | | | | | | | | | | |
Subscription and support (1) | | $ | 11,112 | | $ | 16,950 | | (34) | % | | | | | | |
| Professional services and other | | 822 | | 1,098 | | (25) | % | | | | | | |
| Total cost of revenue | | 11,934 | | 18,048 | | (34) | % | | | | | | |
| Gross profit | | $ | 36,756 | | $ | 45,607 | | (19) | % | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
(1) Includes amortization and stock-based compensation expense as follows: | | | | |
| | | | | | | | | | | | |
| Amortization | | $ | 993 | | $ | 1,666 | | | | | | | | |
| Stock-based compensation | | $ | 86 | | $ | 121 | | | | | | | | |
For the Three Months Ended March 31, 2026
Cost of subscription and support revenue was $11.1 million in the three months ended March 31, 2026, compared to $17.0 million in the three months ended March 31, 2025, a decrease of $5.9 million, or 34%. The decrease related to divested product lines was $5.7 million attributable to infrastructure costs, variable telecom carrier costs, personnel costs and non-cash amortization of divested intangibles. The decrease related to Sunset assets was $0.2 million, primarily attributable to personnel-related costs. A decrease of $0.3 million in non-cash amortization of intangibles in our on-going product lines was offset by a $0.3 million increase in infrastructure costs.
Cost of professional services and other revenue was $0.8 million in the three months ended March 31, 2026, compared to $1.1 million in the three months ended March 31, 2025, a decrease of $0.3 million, or 25%. The decrease in cost of professional services and other revenue was comprised of a decrease in personnel-related expenses of $0.1 million in our divested product lines and $0.2 million in our on-going product lines due to lower professional services revenue in our core products.
Operating Expenses
Sales and Marketing Expense | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
Sales and marketing (1) | | $ | 9,472 | | $ | 13,756 | | (31) | % | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
(1) Includes stock-based compensation expense as follows: | | | | | | | | |
| Stock-based compensation | | $ | 30 | | $ | 252 | | | | | | | | |
For the Three Months Ended March 31, 2026
Sales and marketing expense was $9.5 million in the three months ended March 31, 2026, compared to $13.8 million in the three months ended March 31, 2025, a decrease of $4.3 million, or 31%. The decrease related to divested product lines was $2.9 million in personnel-related costs. The remaining decrease was due to declines in personnel-related costs of $0.1 million related to our Sunset Assets, and declines in personnel-related costs of $1.3 million related to our core product lines.
Research and Development Expense | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
Research and development (1) | | $ | 8,044 | | $ | 11,542 | | (30) | % | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
(1) Includes stock-based compensation expense as follows: | | | | | | | | |
| Stock-based compensation | | $ | 83 | | $ | 290 | | | | | | | | |
For the Three Months Ended March 31, 2026
Research and development expense was $8.0 million in the three months ended March 31, 2026, compared to $11.5 million in the three months ended March 31, 2025, a decrease of $3.5 million, or 30%. The decrease in research and development expense is primarily attributable to a $2.1 million decrease in personnel-related costs in our divested product lines and a $1.4 million decrease in personnel-related and contractor costs in our remaining product lines. The decrease in research and development expense in our core product lines reflects the 2025 termination of our out-sourced research and development contract and the continued use of our India Center of Excellence.
General and Administrative Expense | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
General and administrative (1) | | $ | 8,538 | | $ | 11,621 | | (27) | % | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
(1) Includes stock-based compensation expense as follows: | | | | |
| Stock-based compensation | | $ | 762 | | $ | 2,012 | | | | | | | | |
For the Three Months Ended March 31, 2026
General and administrative expense was $8.5 million in the three months ended March 31, 2026, compared to $11.6 million in the three months ended March 31, 2025, a decrease of $3.1 million, or 27%. This decrease is primarily due to a decrease of $2.5 million in personnel-related costs related to our on-going product lines due to decreased headcount including a decrease of $1.2 million in non-cash stock-based compensation expense. Software costs related to core product lines declined $0.2 million due to cost savings and professional fees declined $0.1 million. The decrease related to our divested product lines was $0.3 million.
Depreciation and Amortization Expense | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
| Depreciation and amortization: | | | | | | | | | | | | |
| Depreciation | | $ | 213 | | $ | 260 | | (18) | % | | | | | | |
| Amortization | | 5,418 | | 7,735 | | (30) | % | | | | | | |
| Total depreciation and amortization | | $ | 5,631 | | $ | 7,995 | | (30) | % | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
For the Three Months Ended March 31, 2026
Depreciation and amortization expense was $5.6 million in the three months ended March 31, 2026, compared to $8.0 million in the three months ended March 31, 2025, a decrease of $2.4 million, or 30%. $0.7 million of the decrease resulted from the decline in amortization from intangible assets associated with Sunset Assets and $1.7 million of the decrease resulted from the decline in amortization from intangible assets associated with our divested product lines.
Divestiture-related Expenses | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
| Divestiture-related expenses | | $ | 22 | | $ | 1,745 | | (100) | % | | | | | | |
| | | | | | | | | | | | |
For the Three Months Ended March 31, 2026
Divestiture-related expenses were nominal in the three months ended March 31, 2026, compared to $1.7 million in the three months ended March 31, 2025. In conjunction with the divestitures completed in the first quarter of 2025, we incurred $1.7 million in legal, accounting and other professional fees. Limited divestiture-related expenses were incurred in the three months ended March 31, 2026 as final expenses were incurred related to the 2025 divestitures and no divestitures were executed in 2026.
Other Expense | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
| Other expense: | | | | | | | | | | | | |
| Interest expense, net | | $ | (4,459) | | $ | (2,443) | | (83) | % | | | | | | |
| Loss on divestitures of businesses | | — | | (23,457) | | (100) | % | | | | | | |
| | | | | | | | | | | | |
| Other income (expense), net | | (834) | | (241) | | 246 | % | | | | | | |
| Total other expense | | $ | (5,293) | | $ | (26,141) | | (80) | % | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
For the Three Months Ended March 31, 2026
Interest expense, net was $4.5 million in the three months ended March 31, 2026 compared to $2.4 million in the three months ended March 31, 2025, an increase of $2.1 million in net interest expense. This was primarily due to the effects of our interest rate derivatives which reduced interest expense by $1.2 million in the three months ended March 31, 2026 and by $3.4 million in the three months ended March 31, 2025, resulting in a $2.2 million year over year increase in interest expense. In addition, interest income for the three months ended March 31, 2026 declined $0.1 million from interest income in the three months ended March 31, 2025 due to lower cash and cash equivalents. These increases were offset by a $0.1 million decline in interest expense, driven by the decrease in our outstanding debt balance, which more than offset the impact of higher interest rates, as well as a $0.2 million reduction related to the amortization of deferred financing costs.
No divestitures were closed in the three months ended March 31, 2026. In the three months ended March 31, 2025, we finalized the divestitures of certain product lines in order to focus on our higher margin and higher growth potential product lines.
Other income (expense), net recognized during the three months ended March 31, 2026 and 2025 was related primarily to foreign currency exchange fluctuations.
Benefit from Income Taxes | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2026 | | 2025 | | % Change | | | | | | |
| | | | | | | | | | | | |
| | (dollars in thousands) |
| Benefit from (provision for) income taxes | | $ | (986) | | $ | 1,345 | | (173) | % | | | | | | |
| | | | | | | | | | | | |
For the Three Months Ended March 31, 2026
The provision for income taxes was $1.0 million in the three months ended March 31, 2026, compared to a benefit from income taxes of $1.3 million in the three months ended March 31, 2025, resulting in an additional expense from income taxes of $2.3 million. The provision for income taxes for the three months ended March 31, 2026 relates primarily to income tax from non-U.S. operations. The benefit from income taxes in the three months ended March 31, 2025 relates primarily to the deferred tax benefit from the business divestitures in the first quarter of 2025. This tax benefit is partially offset by the income tax from non-U.S. and U.S. operations.
Liquidity and Capital Resources
We have financed our operations primarily through cash generated from operating activities, the raising of capital including sales of our Common Stock or our convertible preferred stock, and borrowings under credit facilities.
As of March 31, 2026, we had $30.4 million of cash, cash equivalents and restricted cash and $233.7 million of debt outstanding under our Credit Agreement. As of December 31, 2025, we had $30.0 million of cash, cash equivalents and restricted cash and $238.5 million of borrowings outstanding under our previous senior secured credit facility. The $0.4 million increase in cash, cash equivalents and restricted cash from December 31, 2025 to March 31, 2026 was primarily due to $5.6 million in cash inflows from operations netted with $4.8 million in debt repayments made in the three months ended March 31, 2026. Other uses of cash included $0.1 million in purchases of leasehold improvements and equipment and $0.2 million negative effect of exchange rates during the three months ended March 31, 2026.
Our cash and cash equivalents held by our foreign subsidiaries was $13.2 million as of March 31, 2026 and $10.0 million as of December 31, 2025. Our intent is to either permanently reinvest these funds outside the U.S. or use these funds to repay certain long-term intercompany loans. We do not provide for federal income taxes on the undistributed earnings of our foreign subsidiaries.
We believe our available cash and cash equivalents, together with our positive cash flows from operations and the liquidity provided by our $30 million revolving credit facility will be sufficient to meet our anticipated cash needs.
The following table summarizes our cash flows for the periods indicated:
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2026 | | 2025 |
| | | |
| (dollars in thousands) |
| Consolidated Statements of Cash Flows data: | | | |
| Net cash provided by operating activities | $ | 5,603 | | | $ | 8,305 | |
| Net cash provided by investing activities | 96 | | | 3,789 | |
| Net cash used in financing activities | (5,109) | | | (34,723) | |
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | (207) | | | (92) | |
| Change in cash, cash equivalents and restricted cash | 383 | | | (22,721) | |
| Cash, cash equivalents and restricted cash, beginning of period | 30,024 | | | 57,052 | |
| Cash, cash equivalents and restricted cash, end of period | $ | 30,407 | | | $ | 34,331 | |
Cash Flows from Operating Activities
Cash provided by operating activities is significantly influenced by the amount of cash we invest in personnel and infrastructure to support the growth of our business. Our working capital consists primarily of cash, receivables from customers, prepaid assets, unbilled professional services, deferred commissions, accounts payable, accrued compensation and other accrued expenses, lease liabilities, and deferred revenues. The volume of professional services rendered, the volume and timing of customer bookings and contract renewals, and the related timing of collections on those bookings and renewals, as well as the timing of spending commitments and payments of our accounts payable, accrued expenses, accrued payroll and related benefits, all affect these account balances.
Cash provided by operating activities was $5.6 million for the three months ended March 31, 2026 compared to cash provided by operating activities of $8.3 million for the three months ended March 31, 2025, a decrease of approximately $2.7 million. This decrease was primarily due to a reduction in accrued compensation and other accrued expenses combined with reduced accounts receivable due to the divestitures completed in 2025.
A substantial source of cash is invoicing for subscriptions and support fees in advance, which is recorded as deferred revenue, and is included on our condensed consolidated balance sheets as a liability. Deferred revenue consists of the unearned portion of booked fees for our software subscriptions and support, which is amortized into revenue in accordance with our revenue recognition policy. We assess our liquidity, in part, through an analysis of new subscriptions invoiced, expected cash receipts on new and existing subscriptions, and our ongoing operating expense requirements.
Cash Flows from Investing Activities
Historically, our investing activities have consisted of routine purchases of office equipment. Other activities, such as divestitures of businesses including the collections on note receivable from divested product lines, and purchases of other fixed assets, may affect our cash flows from investing activities in such periods as these transactions occur.
Cash provided by investing activities was $0.1 million for the three months ended March 31, 2026 compared to cash provided by investing activities of $3.8 million for the three months ended March 31, 2025, a decrease of $3.7 million. Cash activity consisted of $0.2 million in collections on the note receivable related to divestitures and $0.1 million in purchases of leasehold improvements and equipment for the three months ended March 31, 2026 compared to cash proceeds from divestitures of businesses of $4.2 million and $0.4 million in purchases of leasehold improvements and equipment for the three months ended March 31, 2025.
Cash Flows from Financing Activities
Historically, our primary financing activities have consisted of capital raises, proceeds from debt obligations, repayments and servicing of our debt obligations, share repurchases and share based employee payroll tax payment activity.
Cash used in financing activities was $5.1 million for the three months ended March 31, 2026 compared to $34.7 million for the three months ended March 31, 2025, a decrease of $29.6 million of cash used primarily due to $4.8 million in payments on our outstanding debt in the three months ended March 31, 2026 as compared to $34.2 million in payments made in the three months ended March 31, 2025.
Critical Accounting Policies and the Use of Estimates
We prepare our condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of our condensed consolidated financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. We believe that the accounting policy discussed below is critical to understanding our historical and future performance, as this policy relates to a more significant area involving management’s judgments and estimates.
Goodwill Impairment
We assess goodwill for impairment annually on October 1st, or more frequently when an event occurs which could cause the carrying value of the Company to exceed the estimated fair value of the Company.
As we operate as one reporting unit, the goodwill impairment evaluation is performed at the consolidated entity level by comparing the estimated fair value of the Company to its carrying value. We first assess qualitative factors to determine whether it is more likely than not that the fair value of our single reporting unit is less than its carrying value. Qualitative factors considered include: industry and market considerations; macroeconomic conditions; and other relevant events and factors. Based on the qualitative assessment, if it is determined that it is more likely than not that the Company's fair value is less than its carrying value, then we perform a quantitative analysis using a fair-value-based approach to determine if the fair value of our reporting unit is less than its carrying value. Performing a quantitative goodwill impairment test includes the determination of the fair value of a reporting unit and involves significant estimates and assumptions. These estimates and assumptions include, among others, revenue growth rates and operating margins used to calculate projected future cash flows, weighted average cost of capital, and future economic and market conditions. See “Note 4. Goodwill and Other Intangible Assets for more information.
We are not aware of any specific event or circumstance that would require updates to our estimates or judgments or require us to revise the carrying value of our assets or liabilities as of May 1, 2026, the date of issuance of this Quarterly Report on Form 10-Q. Estimates may change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.
Other Key Accounting Policies
Our unaudited interim financial statements and other financial information for the three months ended March 31, 2026, as presented herein and in “Item 1. Financial Statements” to this Quarterly Report on Form 10-Q, reflect no material changes in our critical accounting policies and estimates as set forth in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”). Please refer to our Annual Report for a detailed description of our critical accounting policies that involve significant management judgment.
We evaluate our estimates, judgments and assumptions on an ongoing basis, and while we believe that our estimates, judgments and assumptions are reasonable, they are based upon information available at the time. Actual results may differ significantly from these estimates under different assumptions, judgments or conditions.
Recent Accounting Pronouncements
For information with respect to recent accounting pronouncements and the impact of these pronouncements on our condensed consolidated financial statements, refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies—Recent Accounting Pronouncements” to our condensed consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Our management, including our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2026, the end of the period covered by this Quarterly Report on Form 10-Q. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such date. Our management has concluded that the condensed consolidated financial statements included in this report fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented in conformity with GAAP.
Changes in Internal Control over Financial Reporting
There were no changes to our internal control over financial reporting (as defined in Rules 13a- 15(f) and 15d- 15(f) of the Exchange Act) during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
For discussion regarding our legal proceedings, if any, please refer to Note 8. Commitments and Contingencies in our unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2025 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. There have been no material changes during 2026 to the risk factors that were included in the Company's Annual Report on Form 10-K, other than as set forth below.
Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our common stock, which could negatively impact the market price and liquidity of our common stock and our ability to access the capital markets.
Our common stock is listed on the NASDAQ Global Market, or Nasdaq. In order to maintain this listing, we must satisfy the continued listing requirements and standards of Nasdaq, including a minimum closing bid price requirement for our common stock of $1.00 per share. On April 7, 2026, we received a notification letter from Nasdaq notifying us that, for the last 30 consecutive business days, the closing bid price for our common stock has been below the minimum $1.00 per share required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5450(a)(1) (“Rule 5450(a)(1)”). We have 180 calendar days, or until October 5, 2026, to regain compliance with Rule 5450(a)(1) by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive trading days, subject to Nasdaq’s discretion. If we do not regain compliance with Rule 5450(a)(1) by October 5, 2026, we may be afforded a second 180 calendar day period to regain compliance, subject to meeting applicable listing standards and written notice of our intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split if necessary.
If the closing bid price of our common stock continues to trade below $1.00 per share, we intend to implement a reverse stock split to attempt to regain compliance, as disclosed in our definitive proxy statement filed with the SEC on April 20, 2026. However, a reverse stock split requires stockholder approval, and there can be no assurance that our stockholders will approve the proposal or that a reverse stock split, if effected, would result in our regaining or maintaining compliance with Nasdaq’s continued listing requirements.
If we are unable to regain compliance within the applicable cure period, including any available extension, our common stock would be subject to delisting from Nasdaq. Further, even if we regain compliance, we may not be able to sustain compliance with Rule 5450(a)(1) in the long term. A delisting could significantly reduce the liquidity and market price of our common stock, limit investors’ ability to buy and sell our common stock, reduce analyst coverage, and negatively affect our ability to access the capital markets or complete strategic transactions on favorable terms, or at all. Delisting could also trigger certain contractual provisions or investor concerns that may further adversely affect us.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
On August 15, 2025, the Board of Directors authorized a stock repurchase program (the “2025 Share Repurchase Plan” as defined in Note 10. Stockholders' Deficit) in the aggregate amount of up to $10,000,000 (inclusive of any taxes payable as a result of such repurchase). The authorization does not have a specified expiration date. Accordingly, unless terminated earlier by resolution of the Board, the 2025 Share Repurchase Plan will expire when the Company has repurchased all shares authorized for repurchase thereunder. The Company is not obligated to acquire any particular amount of Common Stock and may modify or suspend the repurchases at any time in the Company’s discretion.
There were no purchases of equity securities that are registered by the Company pursuant to Section 12 of the Exchange Act during the three months ended March 31, 2026. As of March 31, 2026, $9.9 million was still available for share repurchases under the 2025 Share Repurchase Plan.
Item 5. Other Information
Rule 10b5-1 Trading Plans
On March 9, 2026, Timothy Mattox, who serves on the Company’s Board of Directors, adopted a written plan for the sale of up to 58,481 shares of the Company’s Common Stock that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The written plan will expire on August 14, 2026, or on any earlier date on which all of the shares have been sold.
During the three months ended March 31, 2026, none of our other officers (as defined in Rule 16a-1(f)) or directors adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K under the Securities Act).
Item 6. Exhibits
See the Exhibit Index immediately following this page, which is incorporated herein by reference.
EXHIBIT INDEX | | | | | | | | |
| Exhibit Number | | Exhibit Description |
|
| | |
10.1* | | Transition Agreement, dated February 25, 2026, by and between Upland Software, Inc. and John T. McDonald (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on February 25, 2026). |
| | |
10.2*+ | | Offer Letter, dated February 21, 2026, by and between Upland Software, Inc. and Sean Nathaniel |
| | |
31.1* | | Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| | |
31.2* | | Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| | |
32.1** | | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| | |
32.2** | | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| | |
| 101* | | Inline XBRL (Extensible Business Reporting Language). The following materials from this Quarterly Report on Form 10-Q for the periods ended March 31, 2026, formatted in Inline XBRL: (i) condensed consolidated balance sheets of Upland Software, Inc., (ii) condensed consolidated statements of operations of Upland Software, Inc., (iii) condensed consolidated statements of comprehensive income (loss) of Upland Software, Inc., (iv) condensed consolidated statement of stockholders’ deficit of Upland Software, Inc., (v) condensed consolidated statements of cash flows of Upland Software, Inc. and (vi) notes to unaudited condensed consolidated financial statements of Upland Software, Inc. The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. |
| | |
| 104* | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* Filed herewith.
** Furnished herewith.
+ Certain personal information in this exhibit has been omitted in accordance with Regulation S-K Item 601(a)(6).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | |
| UPLAND SOFTWARE, INC. |
| Dated: May 1, 2026 | /s/ Michael D. Hill |
| Michael D. Hill |
| Chief Financial Officer |